Zhi‐Dong Jiang

Statistics

Publications

Citations

3.2K

H-Index

Active since

1995

Affiliations

The University of Texas Health Science Center at Houston(Current)

Baylor College of Medicine

St. Luke's Episcopal Hospital

Instituto Nacional de Salud Pública

The University of Texas MD Anderson Cancer Center

Zhi‐Dong Jiang is an author at The University of Texas Health Science Center at Houston specializing in infectious diseases, infectious diarrhea, and medical microbiology.

ORCID

Publications per year

1995–2023

Publications

Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis

Yinghong Wang, Diana H. Wiesnoski, Beth A. Helmink et al. · Nature Medicine · 2018 · 721 citations

Life Sciences, Immunology, Microbiology +14

A Randomized, Double-Blind, Placebo-Controlled Trial of Rifaximin To Prevent Travelers' Diarrhea

Herbert L. DuPont, Zhi‐Dong Jiang, Pablo C. Okhuysen et al. · Annals of Internal Medicine · 2005 · 228 citations

Medicine, Pharmacology, Pharmacotherapy +16

Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial

Sarah A. Frech, Herbert L. DuPont, A. Louis Bourgeois et al. · The Lancet · 2008 · 204 citations

Life Sciences, Infectious Diseases, Microbiology +12

Randomised clinical trial: faecal microbiota transplantation for recurrent <i>Clostridum difficile</i> infection – fresh, or frozen, or lyophilised microbiota from a small pool of healthy donors delivered by colonoscopy

Zhi‐Dong Jiang, Nadim J. Ajami, J. F. Petrosino et al. · Alimentary Pharmacology & Therapeutics · 2017 · 183 citations

Life Sciences, Infectious Diseases, Microbiology +17

In Vitro Activity and Fecal Concentration of Rifaximin after Oral Administration

Zhi‐Dong Jiang, Ke Shi, Ernesto Palazzini et al. · Antimicrobial Agents and Chemotherapy · 2000 · 182 citations

Medicine, Infectious Diseases, Microbiology +8

1–5 of 31